Share: Subscribe
DistilNFO M&A
Life Sciences M&A Advisory

Weekly Top News

Mon, 02 Mar 2020

We have 34 articles this week. The week’s biggest highlights are as follows : #Takeda Acquires Celiac-Focused PvP Biologics in Deal Worth $330 Million. #Essity Acquires 75% of the Medical Solutions Company #ABIGOMedicalAB. #WaveNeuroscience Acquires Assets of #NeoSync. #NeuroVasc Secures $34 Million in Funding to Support Clinical Trials and Product Development. #Qure.ai scores $16M in funding led by #SequoiaIndia. #BlueShieldCA, #AccoladePartner to Offer Personalized Health for Self-Funded Employers. #TransUnion, #VisitPay to Provide End-to-End Patient Payment Experience

Editor’s Choice
1.
Active Pharmaceutical Ingredients Market (API) Size, Current Trends, Business Opportunities, Market Challenges and Analysis by 2028 | Radiant Insights, Inc
2.
Global Cancer Generics Market Size Sales Drug Dosage Price Insight 2026
3.
$16.6 Billion Hyaluronic Acid Market Insights, 2027 Featuring Roche, Seikagaku, Galderma, Sanofi, Anika Therapeutics, Salix Pharma, Zimmer, Allergan, Ferring Pharma, Smith & Nephew, and More
4.
$15.7 Billion Eclinical Solutions Market Insights, 2020-2027: Focus on ECOA, EDC and CDMS
5.
Pharmaceutical Market Boosting the Growth Worldwide: Pharmaceutical Market Dynamics and Trends, Efficiencies Forecast 2026
Top 10 M&A Transactions
6.
Takeda Acquires Celiac-Focused PvP Biologics in Deal Worth $330 Million
7.
Essity Acquires 75% of the Medical Solutions Company ABIGO Medical AB
8.
Leveragepoint Media’s Rx Edge® Media Network Expands Into Healthcare Provider Channel with Brandperx Acquisition
9.
Breezie™ Announces Acquisition by VitalTech™ Affiliates
10.
Wave Neuroscience Acquires Assets of Neosync
11.
Fluidigm Completes Acquisition of InstruNor AS
12.
Certara’s Simcyp Division Acquires Modeling and Simulation Platform for Neurodegenerative Diseases from in Silico Biosciences, Inc.
13.
Advion, Inc.’s Parent Company, Bohui Innovation Biotechnology, Will Acquire the Interchim Group and Subsequently Combine with Advion. Global Commercial Combination and Impact Should be Notable.
14.
Sharecare Acquires Visualize Health to Drive Better Patient Outcomes
15.
The InterMed Group Acquires Sigma Imaging Technologies
Top 3 Venture Funding
16.
Neurovasc Secures $34 Million in Funding to Support Clinical Trials and Product Development
17.
Backed by Andreessen Horowitz, Ribbon Health Raises $10M for Health Data Platform
18.
Qure.ai Scores $16M in Funding Led By Sequoia India
Top 4 Partnerships Announcements
19.
Blue Shield CA, Accolade Partner to Offer Personalized Health for Self-Funded Employers
20.
Transunion, Visitpay to Provide End-to-end Patient Payment Experience
21.
DrChrono EHR, Cognition IP Partner to Process 5 Machine Learning-based Patents
22.
Hikma and Glenmark Pharmaceuticals Enter Into Exclusive Licensing Agreement for Commercialising Ryaltris™ Seasonal Allergic Rhinitis Nasal Spray in the Us
Read More Corporate Development and M&A Activity
About Ed Francis
DistilNFO's Executive Editor & Industry Strategist.
Ed has more than 25 years of management consulting experience guiding some of the industry's most prominent health and life sciences organizations through complex transformations.

If you need help with your complex transformation whether it be M&A, digital, or strategic cost reduction or need to bring more innovation into your business strategy Ed can be contacted at EdFrancis@hlstransformationpartners.com and +1-847-910-6073

Or connect with him at

Advertise with us

We Reach Quarter Million Decision Makers in:
Healthcare · IT · Retail · Industrial
Advertise with us and reach the right audience.
advertise@distilnfo.com

Contact Us


5760 Legacy Dr,
ste B3-405,
Plano TX 75024
+1 469-270-3311

About DistilNFO Newsletter

We pick up top 10 news from industries relevent to you and send out the headlines weekly thus saving your time and keeping you up to date on your interest areas.

You are receiving this newsletter because you are subscribed to one or more DistilNFO Publications Newsletter/s. If you feel this email was sent by mistake, you can unsubscribe or update your subscription.

View in browser | Update Subscription | Advertise | Contact Us